EUVIMEDEUVIMED entdecken
Crossref

Bromelain, a potential therapeutic compound from ananas comosus

Aydın Alper Şahin

Lokman Hekim Health Sciences · 2021

DOI: 10.14744/lhhs.2021.10001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lokman Hekim Health Sciences, 2021. Verfasst von Aydın Alper Şahin. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bromelain is a mixture of enzymes found in crude extract from the fruit and other parts of the pineapple Ananas comosus (Linn.), Bromeliaceae family. Bromelain is a nontoxic compound having various industrial and therapeutic applications. It consists of varied closely related proteinases that are important as anti-inflammatory, antithrombotic, and fibrinolytic agents. Bromelain is widely administered for its well-known properties, such as anticancer activity, antioxidant activity, and immunomodulatory effects. It also plays a major role in the modulation of the immune system and prevents the harmful effects of the cytokine storm. Because of all these therapeutic effects, bromelain appears to be a potential candidate to inhibit and prevent the symptoms of different diseases as well being an effective, natural, therapeutic weapon for the treatment of severe COVID-19 infection.

Zitieren

APA

Şahin, A. A. (2021). Bromelain, a potential therapeutic compound from ananas comosus. Lokman Hekim Health Sciences. https://doi.org/10.14744/lhhs.2021.10001

Vancouver

Şahin AA. Bromelain, a potential therapeutic compound from ananas comosus. Lokman Hekim Health Sciences. 2021. doi:10.14744/lhhs.2021.10001

BibTeX
@article{ahin2021,
  author = {Şahin, Aydın Alper},
  title = {Bromelain, a potential therapeutic compound from ananas comosus},
  journal = {Lokman Hekim Health Sciences},
  year = {2021},
  doi = {10.14744/lhhs.2021.10001}
}
Kostenlos starten →